Deadly drug stronger than fentanyl spreads rapidly across the Americas, experts warn
Nitazenes, a class of synthetic opioids, were originally developed as pain relievers in the 1950s, but were never approved for use due to the high overdose risk, according to a report from the Inter-American Drug Abuse Control Commission (CICAD).
Starting in 2019, nitazenes (benzimidazole-opioids) began to enter the illicit drug market in Europe, where they have been reported on almost every continent.
CICAD's report suggests that "nitazene use is a growing trend in North America and that availability is likely spreading across the Americas."
The most prevalent type of nitazene is isotonitazene (ISO), but at least a dozen others have been identified, the report stated.
The U.S. Drug Enforcement Administration (DEA) classifies ISO as a Schedule 1 drug, along with seven other nitazenes.
"Nitazenes are being produced in illicit labs overseas, mostly in places like China and India, and are getting trafficked into the U.S. through the same channels used for fentanyl," Corey Gamberg, a licensed alcohol and drug counselor and executive director at the Massachusetts Center for Addiction, told Fox News Digital.
Because they're synthetic and cheap to make, they've become a popular option for illegal manufacturers, the expert noted.
"As authorities crack down on fentanyl, traffickers pivot to new synthetic opioids like nitazenes to get around enforcement," Gamberg went on.
"These drugs are cheap to make and easy to move. It's a pattern we've seen before, and it's repeating itself now."
Nitazenes are available in pills, powders, sprays and other forms. They can be snorted, smoked, injected or taken orally.
The biggest risk is potency, as some types of nitazenes are several times stronger than fentanyl.
"These drugs are cheap to make and easy to move. It's a pattern we've seen before, and it's repeating itself now."
Dr. Jonathan Avery, vice chair of addiction psychiatry at NewYork-Presbyterian/Weill Cornell Medical Center, confirmed that nitazenes can be hundreds of times stronger than morphine and up to 10 times more potent than fentanyl, "making even tiny doses deadly."
In addition to potentially fatal overdoses, the drugs are known to cause dependency, dizziness, nausea, vomiting, disorientation, loss of consciousness, cardiac arrest and seizures, according to the CICAD report.
The other issue is that people usually don't know they're taking them.
"Nitazenes are often mixed into heroin, pressed pills or even stimulants — so someone might think they're using one thing and end up taking something completely different," Gamberg cautioned. "That unpredictability is what makes them so deadly."
Adding to the danger of nitazenes is that testing is very limited, according to Dr. Ryan Marino, a medical toxicologist at Case Western University in Cleveland, Ohio.
"Test strips are available that can help people screen things like powdered drugs and pills for the presence of nitazenes, but more definitive testing is limited to more advanced toxicology labs, and also limited by cost and turnaround time," he told Fox News Digital.
"While test strips are useful, they are not a definitive way to rule out nitazenes in drugs, and more advanced testing for nitazenes is not widely available, even in post-mortem testing."
Routine hospital and workplace drug screens do not reliably detect nitazenes, according to Avery.
"Enforcement is difficult because producers constantly tweak chemical structures to evade laws and standard tests," he said.
To prevent deadly overdoses, Avery called for specialized testing and rapid drug‑checking tools to identify nitazenes in the street supply.
For more Health articles, visit www.foxnews.com/health
"Naloxone (Narcan) can reverse nitazene overdoses, but multiple doses may be needed because of their potency," he said.
"Public awareness, widespread naloxone distribution and rapid drug‑checking are key to preventing deaths."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
4 days ago
- New York Post
Little-known synthetic opioid nitazene is up to 43 times more deadly than fentanyl, resistant to Narcan and killing young Americans
A pair of Texas friends died less than three months apart after ingesting pills laced with a dangerous new synthetic opioid, and now their mothers are begging US officials to sound the alarm on the little-known drug up to 43 times more lethal than fentanyl. The young men both died this year after swallowing different pills secretly tainted with the deadly, often Narcan-resistant opioids known as nitazenes, which have begun seeping into the US at an alarming rate. Lucci Reyes-McCallister, 22, died January 26 near Houston, Texas, after taking a pill labeled as Xanax that was actually laced with N-Pyrrolidino Protonitazene, an emerging form of nitazene. Advertisement 4 Lucci is seen baking with his mother. Youtube / City of League City TX The particular strain of the new synthetic narcotic that killed Lucci is 25 times more lethal than fentanyl, but other nitazenes are between five and 43 times stronger, depending on the type, according to the Inter-American Drug Abuse Control Commission. The stronger the strain, the more resistant the nitazene is to the overdose antidote Narcan, as seen in Lucci's case. Advertisement 'It was the first time I'd ever heard of it,' Lucci's heartbroken mother, Grey McCallister, told The Post of nitazene. 'It took them seven rounds of Narcan to try to revive him,' she said. But Lucci never came to. 4 Lucci died in January after he took a nitazene-laced counterfeit pill. Crowder Funeral Home Advertisement Nearly six months after his death, Grey received a call from another mother in the area who revealed her son also died of the same form of nitazene. It was Lucci's friend, Hunter Clement, 21. Hunter died on April 10 after taking a nitazene-laced pill branded to look like a Percocet. A few weeks after his death, Ruthi came across a news article about the dangers of nitazenes. Advertisement 'I told my husband, 'I feel like that could be what Hunter died from,'' she recalled. Nitazenes are produced in clandestine Chinese labs and may have made their way to the cartels in Mexico using 'their existing relationships' with 'suppliers' in China, according to the Drug Enforcement Administration. The drug was developed over 60 years ago as an alternative to morphine, but was never approved for medical use because of its high risk of overdose. Authorities in Europe have already seen several overdoses from the synthetic narcotic and the devastating poison is now starting to hit US shores more. Last January, a Florida man confessed to distributing protonitazene that he received in the mail from labs in China, according to the IRS. Customs officers at JFK are seeing the drug coming through the airport 'at least a few times a week in quantities ranging from just a few grams to upwards of a pound or more,' Andrew Renna, Assistant Port Director for Cargo Operations at the airport, said in May. And it's all part of China's 'ongoing attack against America,' former acting DEA administrator Derek Maltz told The Post. 'As America is just now really starting to talk about fentanyl, we have now seen all these other substances that are popping up everywhere, and they're coming out of these labs in China,' Maltz said. Medical examiners in Houston and the surrounding Harris County have already seen four cases of nitazene-related overdose deaths, according to the Harris County Institute of Forensic Sciences. Advertisement 4 Hunter Clement pictured in a photo posted to his obituary. Dignity Memorial Hunter's mother, Ruthi Clement, fought through tears as she recalled finding her son that fateful night with his face down in his bed and his body cold and purple. She quickly started giving Hunter chest compressions and two doses of Narcan, but it wasn't enough to save him. 'Sometimes I get mad because I couldn't save my own son, but I do want to save other people, even if it's just one person in honor of him,' Ruthi told The Post. Traditional drug tests don't look for nitazenes since US authorities are just now learning of their existence, the two grieving mothers said. Advertisement 4 A DEA instructor holds a bag of isotonitazene pills. DEA Nitazenes are not in the standard toxicology tests used by Harris County medical examiners and the screenings are only ordered 'if there is suspected nitazene use and there is no other toxicology to explain the death,' the office said. The mothers are now warning America's youth in the hopes of saving lives. 'They could think something is clean or rather safe when it's actually pressed for something that's 20 to 40 times stronger, more deadly than fentanyl,' Grey said. Advertisement 'It just really lit a fire under me. There was no way Lucci was going to die in vain,' she added. Maltz urged the feds to run educational programs and social media awareness campaigns to meet kids on platforms 'where they are.' 'You have to educate these kids, you have to have mandatory education. The social media influencers, the athletes, the role models to speak out on social media sites with these video reels to educate the kids. That's where they are, they're not watching the news,' Maltz said.
The Hill
6 days ago
- The Hill
Should marijuana be rescheduled?
For more than 50 years, dozens of 'controlled substances,' including various pharmaceutical products as well as marijuana, cocaine, heroin and everything in between, have been shoe-horned into five statutory 'Schedules,' according to various criteria set in federal law. While some of these categorizations make sense, others do not. Marijuana (technically, tetrahydrocannabinols or THC, which is the operative chemical in the marijuana plant) falls into the latter category — and perhaps it's time to revisit this aspect of the 'Controlled Substance Schedules.' THC is currently classified at the highest level, that is, as a Schedule I controlled substance — on par with heroin and LSD and having ' no currently accepted medical use.' Even those of us who don't think recreational marijuana use is a good idea can agree that the current scheduling is absurd and erodes institutional trust. Frankly, it is time to reschedule cannabis to where it belongs — Schedule III — which will still limit its availability but also will allow for expanded medical research into therapeutic uses of the drug and restore common sense to federal drug policy. Most people surely recognize that cannabis — whatever they think its legal status should be — is a far cry from heroin and does not belong in the same enforcement category. In contrast, even cocaine is less restricted, categorized as Schedule II. As someone who cares about the rule of law, I know how insidious it is to maintain such clearly nonsensical regulations. It undermines the broader credibility of federal drug scheduling. This anomaly is compounded by the reality that a large majority of states — 40 states, three territories, and the District of Columbia — currently recognize medical uses for cannabis. In other words, most states now contradict the federal position that there is 'no accepted medical use' for cannabis. This tension can be largely resolved without going so far as to legalize recreational use on the federal level. The U.S. Drug Enforcement Administration defines Schedule III drugs as having a moderate to low potential for physical and psychological dependence. Schedule III currently includes anabolic steroids, testosterone and ketamine, to name a few. Cannabis would fit far more sensibly in that list. Rescheduling cannabis is not merely a bureaucratic reshuffling. Its Schedule I status creates major barriers for researchers and doctors wishing to study potential therapeutic uses. Further, it creates burdensome red tape that slows scientific progress. It demonstrably is not the case that no medical value can be had from marijuana. It has been used effectively to help patients with epilepsy, chronic pain, PTSD and chemotherapy-induced nausea. The notion that there is no known medical use for cannabis and cannabis-derived medication is clearly outdated. As a conservative, I have always believed that cutting regulatory red tape spurs economic growth. This would be the case for rescheduling cannabis; a straightforward change would support more than 440,000 existing jobs and open the door to future growth. It would lead to more American jobs in research and medicine, generating therapeutic breakthroughs and boosting the economy. If the Trump administration moves forward with cannabis rescheduling, it is critical that they do it the right way. I've spent enough time in Washington to know that stuffing such a change into an omnibus spending bill is not the answer. Nor is an executive order the right vehicle for this policy shift, since rescheduling could easily be undone by a future administration. Instead, the federal government should reschedule cannabis via the official rulemaking process, which would involve the Drug Enforcement Administration and the Department of Justice in coordination with the White House and other executive branch stakeholders. Taking an objective view of the current cannabis policy landscape, it is clear that both scientific and cultural attitudes about marijuana have progressed dramatically in recent years. It is time for the federal government to catch up. Rescheduling marijuana to a Schedule III controlled substance is a substantive but nuanced way to do so without legalizing the drug wholesale. Ultimately, cannabis is a drug that can have genuine medical benefits and its therapeutic uses warrant further research. Rescheduling marijuana to a more sensible classification will unlock new research, new jobs and help restore credibility to federal drug laws. Bob Barr represented Georgia's 7th District in the U.S. House of Representatives from 1995 to 2003. He served previously as the United States Attorney in Atlanta from 1986 to 1990 and was an official with the CIA in the 1970s. He now practices law in Atlanta, serves as head of Liberty Guard, and is the immediate past president of the National Rifle Association of America.
Yahoo
7 days ago
- Yahoo
Deadly drug stronger than fentanyl spreads rapidly across the Americas, experts warn
A little-known opioid that's deadlier than fentanyl has led to a growing number of overdose deaths in recent years. Nitazenes, a class of synthetic opioids, were originally developed as pain relievers in the 1950s, but were never approved for use due to the high overdose risk, according to a report from the Inter-American Drug Abuse Control Commission (CICAD). Starting in 2019, nitazenes (benzimidazole-opioids) began to enter the illicit drug market in Europe, where they have been reported on almost every continent. Deadly Substance Under Scrutiny As Kratom Byproduct Shows Up In Gas Stations, Smoke Shops CICAD's report suggests that "nitazene use is a growing trend in North America and that availability is likely spreading across the Americas." The most prevalent type of nitazene is isotonitazene (ISO), but at least a dozen others have been identified, the report stated. Read On The Fox News App The U.S. Drug Enforcement Administration (DEA) classifies ISO as a Schedule 1 drug, along with seven other nitazenes. "Nitazenes are being produced in illicit labs overseas, mostly in places like China and India, and are getting trafficked into the U.S. through the same channels used for fentanyl," Corey Gamberg, a licensed alcohol and drug counselor and executive director at the Massachusetts Center for Addiction, told Fox News Digital. Here's What Marijuana Really Does To The Developing Brain, According To A Psychiatrist Because they're synthetic and cheap to make, they've become a popular option for illegal manufacturers, the expert noted. "As authorities crack down on fentanyl, traffickers pivot to new synthetic opioids like nitazenes to get around enforcement," Gamberg went on. "These drugs are cheap to make and easy to move. It's a pattern we've seen before, and it's repeating itself now." Nitazenes are available in pills, powders, sprays and other forms. They can be snorted, smoked, injected or taken orally. The biggest risk is potency, as some types of nitazenes are several times stronger than fentanyl. Dr. Jonathan Avery, vice chair of addiction psychiatry at NewYork-Presbyterian/Weill Cornell Medical Center, confirmed that nitazenes can be hundreds of times stronger than morphine and up to 10 times more potent than fentanyl, "making even tiny doses deadly." In addition to potentially fatal overdoses, the drugs are known to cause dependency, dizziness, nausea, vomiting, disorientation, loss of consciousness, cardiac arrest and seizures, according to the CICAD report. The other issue is that people usually don't know they're taking them. "Nitazenes are often mixed into heroin, pressed pills or even stimulants — so someone might think they're using one thing and end up taking something completely different," Gamberg cautioned. "That unpredictability is what makes them so deadly." Adding to the danger of nitazenes is that testing is very limited, according to Dr. Ryan Marino, a medical toxicologist at Case Western University in Cleveland, Ohio. "Test strips are available that can help people screen things like powdered drugs and pills for the presence of nitazenes, but more definitive testing is limited to more advanced toxicology labs, and also limited by cost and turnaround time," he told Fox News Digital. "While test strips are useful, they are not a definitive way to rule out nitazenes in drugs, and more advanced testing for nitazenes is not widely available, even in post-mortem testing." Routine hospital and workplace drug screens do not reliably detect nitazenes, according to Avery. Click Here To Sign Up For Our Health Newsletter "Enforcement is difficult because producers constantly tweak chemical structures to evade laws and standard tests," he said. To prevent deadly overdoses, Avery called for specialized testing and rapid drug‑checking tools to identify nitazenes in the street supply. For more Health articles, visit "Naloxone (Narcan) can reverse nitazene overdoses, but multiple doses may be needed because of their potency," he said. "Public awareness, widespread naloxone distribution and rapid drug‑checking are key to preventing deaths."Original article source: Deadly drug stronger than fentanyl spreads rapidly across the Americas, experts warn
